Ariz. Admin. Code § R4-38-112 - Peer Review
A. A
licensee using an experimental form of diagnosis and treatment such as vaccine
therapy for cancer without affiliation with a recognized research institution,
institutional review board, or peer review committee may request or the Board
may require review of the procedure by the Board or a Board-appointed peer
review committee.
B. In conducting
the review, the Board or Board-appointed peer review committee shall examine
protocols, recordkeeping, analyses of results, and informed patient consent
forms and procedures. Based on the review, the Board shall determine the
licensee's compliance with generally accepted homeopathic experimental criteria
under A.R.S. §
32-2933(27).
C. As used in A.R.S. §
32-2933(27),
"periodic review by a peer review committee" means peer review for compliance
with any form of experimental medicine occurs at a minimum of five-year
intervals through a recognized research institution, institutional review
board, or a peer review committee. The chairperson of a Board-appointed peer
review committee shall be appointed by the Board president and approved by the
Board.
D. During a review of a
licensee's use of experimental forms of diagnosis and treatment or at any other
time the Board deems appropriate, the licensee shall submit informed patient
consent forms and protocols and other records indicating the licensee's
compliance with generally accepted experimental criteria designated in A.R.S.
§ 32-2933(27).
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.